Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Sealed vial Clear label, lot traceability, protective packaging
Calhoun* and Bill T
This multi-receptor approach distinguishes it from existing licensed medicines such as semaglutide (Ozempic, Wegovy) or tirzepatide licensed in the UK as Mounjaro for type 2 diabetes and as Zepbound for obesity which act on fewer receptor pathways
GHK-Cu is for research use only and is not for human consumption
Pellentesque viverra, enim et pulvinar aliquet, dolor magna gravida lectus, sit amet pellentesque turpis elit id enim
US$ 22.97
US$ 24.96
US$ 27.44
US$ 25.37
US$ 28.88
